These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6772384)

  • 21. [Specific mechanism of action of calcium antagonists in the neutralization of experimental coronary spasms].
    Fleckenstein-Grün G; Makita YJ; Byon YK; Frey M
    Z Kardiol; 1984; 73 Suppl 2():71-7. PubMed ID: 6099011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cellular mechanisms of hypoxic coronary spasm].
    Solov'ev AI
    Fiziol Zh SSSR Im I M Sechenova; 1988 Feb; 74(2):193-201. PubMed ID: 3259515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of diltiazem and nitroglycerin on prostaglandin F2 alpha-induced periodic contractions of isolated human coronary arteries.
    Kawasaki K; Seki K; Miyazawa I; Matsumoto N; Nakanishi N; Iino T; Hosoda S
    Jpn Circ J; 1985 Feb; 49(2):145-54. PubMed ID: 3919196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smooth muscles from spastic coronary artery segments show hypercontractility to histamine.
    Satoh S; Tomoike H; Mitsuoka W; Egashira S; Tagawa H; Kuga T; Nakamura M
    Am J Physiol; 1990 Jul; 259(1 Pt 2):H9-13. PubMed ID: 2375416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery spasm induced in atherosclerotic miniature swine.
    Shimokawa H; Tomoike H; Nabeyama S; Yamamoto H; Araki H; Nakamura M; Ishii Y; Tanaka K
    Science; 1983 Aug; 221(4610):560-2. PubMed ID: 6408736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activation mechanisms for contractions of the smooth musculature of the cerebral vessels].
    Orlov RS; Azin AL; Brazgovskiĭ VA; Ignatenko AS; Plekhanov IP
    Fiziol Zh SSSR Im I M Sechenova; 1975 Oct; 61(10):1458-65. PubMed ID: 1204858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanical activity of isolated canine coronary arteries after coronary occlusion.
    Golenhofen K; Mandrek K; Schaper W; Weinheimer G; Wiegand W
    Basic Res Cardiol; 1981; 76(5):480-4. PubMed ID: 7305819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of diltiazem and nitroglycerin on cytosolic Ca2+ concentration and on force in the bovine ophthalmic artery.
    Hiroishi G; Kobayashi S; Nishimura J; Inomata H; Kanaide H
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2612-23. PubMed ID: 8977475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal models of coronary spasm and the pathophysiological events in regional vascular hypercontraction.
    Tomoike H
    Jpn Circ J; 1985 Jan; 49(1):101-7. PubMed ID: 3968859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of static loads on the contractile activity of myocytes of the small coronary arteries].
    Shishkin SB; Baranov AG; Chebukov OP
    Fiziol Zh SSSR Im I M Sechenova; 1984 Jan; 70(1):38-41. PubMed ID: 6698249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
    Godfraind T; Salomone S; Dessy C; Verhelst B; Dion R; Schoevaerts JC
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S34-41. PubMed ID: 1282611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries.
    Ginsburg R; Bristow MR; Davis K; Dibiase A; Billingham ME
    Circulation; 1984 Feb; 69(2):430-40. PubMed ID: 6690108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction between human urotensin II and vasodilator agents in human internal mammary artery with possible clinical implications.
    Bai XY; Liu XC; Yang Q; Tang XD; He GW
    Ann Thorac Surg; 2011 Aug; 92(2):610-6. PubMed ID: 21704284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of norepinephrine on BAY K-8644-induced contraction in porcine coronary artery.
    Perlmutter B; Kennedy RH; Seifen E; Soulsby M
    Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):80-6. PubMed ID: 2437872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm-related coronary arteries in patients with variant angina.
    Lee SJ; Park SJ; Park SW; Kim JJ; Song JK; Hong MK; Kang DH; Cheong SS
    Int J Cardiol; 1996 Jul; 55(2):117-26. PubMed ID: 8842780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin.
    Okumura K; Yasue H; Matsuyama K; Ogawa H; Kugiyama K; Ishizaka H; Sumida H; Fujii H; Matsunaga T; Tsunoda R
    J Am Coll Cardiol; 1996 Jan; 27(1):45-52. PubMed ID: 8522709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasodilator mechanism of KB-944, a new calcium antagonist.
    Morita T; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of inhibitors of arachidonic acid metabolism and calcium entry on responses to acetylcholine, potassium and norepinephrine in the isolated canine saphenous vein.
    Rimele TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1983 Jun; 225(3):720-8. PubMed ID: 6408242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.